Jopari and Verisk partner to streamline insurance medical record review

Published 07/10/2025, 15:22
Jopari and Verisk partner to streamline insurance medical record review

CONCORD, Calif. - Jopari Solutions and Verisk (NASDAQ:VRSK), a $34 billion market cap analytics powerhouse with impressive 69% gross profit margins, announced Tuesday a new collaboration that aims to accelerate and improve insurance medical record review processes through artificial intelligence and data analytics. According to InvestingPro data, Verisk maintains strong financial health with steady 7.6% revenue growth, supporting its continued investment in advanced technologies.

The partnership will integrate Verisk’s GenAI- and AI-powered medical record review and severity scoring models with Jopari’s electronic delivery network of 2.9 million healthcare participants nationwide. The combined solution is designed to reduce manual processing time and improve decision-making accuracy throughout the claims lifecycle.

Medical record review has traditionally been one of the most time-consuming aspects of claims settlement, often taking hours or days to complete manually. According to the companies, the integration will enable claims organizations to identify high-risk claims earlier and process information more efficiently.

"By combining Jopari’s nationwide healthcare provider delivery infrastructure with Verisk’s advanced AI and analytics, we will give carriers the ability to intervene earlier, process smarter, and resolve claims faster," said Steve Stevens, CEO of Jopari Solutions, in the press release statement.

Verisk’s AI-powered medical record review technology reportedly cuts insurance medical record processing times by up to 90 percent compared to manual processes. The collaboration aims to embed this technology directly into existing workflows.

"Our clients are asking for smarter, more connected solutions," said Carrie Barr, president of Casualty Solutions at Verisk.

The companies plan to share additional details about their collaboration at the National Workers’ Compensation and Disability Conference in Nashville, Tennessee, on November 11-12, 2025.

In other recent news, Verisk Analytics has seen a flurry of activity. Seaport Global Securities initiated coverage on Verisk Analytics with a Buy rating and a price target of $280, highlighting the company’s stable recurring revenue stream through its Insurance Services Office. RBC Capital reiterated an Outperform rating with a price target of $314, expecting Verisk to achieve 7.3% organic growth while maintaining its fiscal year 2025 guidance. Additionally, Wolfe Research began coverage with an Outperform rating and a $320 price target, citing Verisk’s strong structural position and industry-leading margins.

In leadership updates, Verisk announced the appointment of Saurabh Khemka as president of Underwriting Solutions. Khemka, with over 12 years at the company, previously served as co-president of Underwriting Solutions. On the innovation front, Verisk launched XactAI, a suite of AI-powered tools designed to streamline claims processing by automating various administrative tasks. These developments reflect Verisk’s ongoing efforts to enhance its offerings and maintain its market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.